The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial
<b>Introduction:</b> In phenylketonuria (PKU), evidence suggests that casein glycomacropeptide supplemented with rate-limiting amino acids (CGMP-AA) is associated with better protein utilisation and less blood phenylalanine (Phe) variability. <b>Aim:</b> To study the impact o...
Main Authors: | Anne Daly, Sharon Evans, Satnam Chahal, Saikat Santra, Alex Pinto, Cerys Gingell, Júlio César Rocha, Francjan van Spronsen, Richard Jackson, Anita MacDonald |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/11/3/520 |
Similar Items
-
Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU
by: A. Daly, et al.
Published: (2019-02-01) -
Dietary management of maternal phenylketonuria with glycomacropeptide and amino acids supplements: A case report
by: A. Pinto, et al.
Published: (2017-12-01) -
Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective
by: Maria João Pena, et al.
Published: (2021-02-01) -
Glycomacropeptide-Based Protein Substitutes for Children with Phenylketonuria in Italy: A Nutritional Comparison
by: Martina Tosi, et al.
Published: (2024-03-01) -
Phenylketonuria (PKU): A problem solved?
by: Christine S. Brown, et al.
Published: (2016-03-01)